leniolisib

FDA approves Pharming drug for ultra-rare immunodeficiency disease
Endpoints
Sun, 03/26/23 - 11:16 pm
FDA
Pharming
Novartis
leniolisib
APDS
Former Novartis drug for ultra-rare disease gets speedy FDA review
Endpoints
Wed, 09/28/22 - 10:58 am
Pharming
Novartis
leniolisib
APDS
FDA
Novartis sells phase 3 rare disease drug to Pharming
Fierce Biotech
Tue, 08/13/19 - 10:06 am
Novartis
Pharming
leniolisib